Clinical Trials | December 07, 2025
Bayer launches phase III trial testing Mirena for uterine condition with no treatments
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
The Eurasian Patent Organization (EAPO) has granted Patent, protecting the company’s sublingual delivery technology for anticancer drugs used to treat autoimmune and neurodegenerative diseases
Subscribe To Our Newsletter & Stay Updated
